Literature DB >> 8943735

Transforming growth factor-beta production during the development of renal fibrosis in rats with subtotal renal ablation.

T M Coimbra1, J Carvalho, A Fattori, C G Da Silva, J J Lachat.   

Abstract

The histologic changes observed in the remnant kidney model include progressive mesangial expansion with collapse of capillary lumina, interstitial fibrosis and mononuclear cellular infiltration. Transforming growth factor-beta (TGF-beta 1) is an important regulator of extracellular matrix formation. The purpose of this study was to investigate the production and distribution of TGF-beta 1 in the kidney during the development of glomerulosclerosis and renal fibrosis in rats with subtotal renal ablation. Eighty-two female Wistar rats weighing 180-220 g were divided into two groups: 49 rats were subjected to 5/6 renal ablation and 33 to sham operation. Urinary albumin excretion, blood pressure and glomerular filtration rate (GFR) were evaluated after the surgical procedure. We also performed histology and immunohistochemistry and determined mRNA for TGF-beta 1 in the kidneys of these rats 8, 15, 30 and 90 days after operation. The results showed progressively higher immunohistochemical TGF-beta 1 staining in rats with subtotal renal ablation. Cortical renal content of TGF-beta 1 mRNA was also higher in these animals and peaked at day 15. The existence of a temporal association between glomerulosclerosis, interstitial fibrosis and intense mononuclear cellular infiltration on the one hand and higher immunohistochemical TGF-beta 1 staining in the renal cortex on the other show that this polypeptide may contribute to the development of renal fibrosis in this model.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8943735      PMCID: PMC2691632          DOI: 10.1046/j.1365-2613.1996.d01-217.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  7 in total

1.  Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.

Authors:  Na Liu; Jian-Kan Guo; Maoyin Pang; Evelyn Tolbert; Murugavel Ponnusamy; Rujun Gong; George Bayliss; Lance D Dworkin; Haidong Yan; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2012-02-23       Impact factor: 10.121

Review 2.  Neuroinflammatory Mechanisms of Connective Tissue Fibrosis: Targeting Neurogenic and Mast Cell Contributions.

Authors:  Michael J Monument; David A Hart; Paul T Salo; A Dean Befus; Kevin A Hildebrand
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-03-01       Impact factor: 4.730

3.  Kinetics of transforming growth factor-beta1 and extracellular matrix in renal tubulointerstitial lesions of mercuric chloride-treated Brown Norway rats.

Authors:  K Suzuki; K Uetsuka; H Nakayama; K Doi
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

4.  Enhancer of Zeste Homolog 2 Inhibition Attenuates Renal Fibrosis by Maintaining Smad7 and Phosphatase and Tensin Homolog Expression.

Authors:  Xiaoxu Zhou; Xiujuan Zang; Murugavel Ponnusamy; Monica V Masucci; Evelyn Tolbert; Rujun Gong; Ting C Zhao; Na Liu; George Bayliss; Lance D Dworkin; Shougang Zhuang
Journal:  J Am Soc Nephrol       Date:  2015-12-23       Impact factor: 10.121

5.  Deficiency in Six2 during prenatal development is associated with reduced nephron number, chronic renal failure, and hypertension in Br/+ adult mice.

Authors:  Ben Fogelgren; Shiming Yang; Ian C Sharp; Odaro J Huckstep; Wenbin Ma; S J Somponpun; Edward C Carlson; Catherine F T Uyehara; Scott Lozanoff
Journal:  Am J Physiol Renal Physiol       Date:  2009-02-04

6.  TGF-Beta Blockade Increases Renal Inflammation Caused by the C-Terminal Module of the CCN2.

Authors:  Raquel Rodrigues-Díez; Sandra Rayego-Mateos; Macarena Orejudo; Luiz Stark Aroeira; Rafael Selgas; Alberto Ortiz; Jesús Egido; Marta Ruiz-Ortega
Journal:  Mediators Inflamm       Date:  2015-05-05       Impact factor: 4.711

7.  Pharmacological targeting of BET proteins inhibits renal fibroblast activation and alleviates renal fibrosis.

Authors:  Chongxiang Xiong; Monica V Masucci; Xiaoxu Zhou; Na Liu; Xiujuan Zang; Evelyn Tolbert; Ting C Zhao; Shougang Zhuang
Journal:  Oncotarget       Date:  2016-10-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.